… And Joins With SAFC To Make Conjugates | Chemical & Engineering News
Volume 92 Issue 40 | p. 21 | Concentrates
Issue Date: October 6, 2014

… And Joins With SAFC To Make Conjugates

Department: Business
Keywords: custom chemicals, drug manufacturing, antibody drug conjugate
[+]Enlarge
SAFC makes antibody-drug conjugates at this facility in St. Louis.
Credit: SAFC
A worker at Sigma-Aldrich’s St. Louis ADC facility.
 
SAFC makes antibody-drug conjugates at this facility in St. Louis.
Credit: SAFC

Sigma-Aldrich’s SAFC custom manufacturing business will collaborate with Baxter’s BioPharma Solutions unit to produce antibody-drug conjugates. SAFC will contribute capability for manufacturing drug linkers and conducting conjugations, while Baxter will provide sterile drug product filling and finishing services. Together, the companies hope to provide customers with end-to-end contract manufacturing in which a bulk drug substance conjugated by SAFC is transferred to Baxter for final steps including filling, regulatory testing, and packaging.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment